Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 7;25(45):6619-6633.
doi: 10.3748/wjg.v25.i45.6619.

MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription

Affiliations

MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription

Liang Ge et al. World J Gastroenterol. .

Abstract

Background: Gastric cancer (GC) has become a serious threat to people's health. Accumulative evidence reveals that dysregulation of numerous microRNAs (miRNAs) has been found during malignant formation. So far, the role of microRNA-760 (miR-760) in the development of GC is largely unknown.

Aim: To measure the expression level of miR-760 in GC and investigate its role in gastric tumorigenesis.

Methods: Real-time quantitative polymerase chain reaction and Western blot analysis were used to measure the expression of miR-760 and G-protein-coupled receptor kinase interacting protein-1 (GIT1). Cell growth was detected by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and cell colony formation assays. Apoptosis was assessed by flow cytometric analysis. The relationship between miR-760 and GIT1 was verified by luciferase reporter assay.

Results: The results showed that the expression of miR-760 was decreased in GC and associated with poor clinical outcomes in GC patients. Furthermore, miR-760 restrained cell proliferation and cell colony formation and induced apoptosis in GC cells. In addition, miR-760 directly targeted GIT1 and negatively regulated its expression in GC. GIT1 was upregulated in GC and predicted a worse prognosis in GC patients. We also found that upregulation of GIT1 weakened the inhibitory effect of miR-760 in GC.

Conclusion: In conclusion, miR-760 targets GIT1 to inhibit cell growth and promote apoptosis in GC cells. Our data demonstrate that miR-760 may be a potential target for the treatment of GC.

Keywords: G-protein-coupled receptor kinase interacting protein-1; Gastric cancer; Invasion; MicroRNA-760; Migration; Proliferation.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The expression of microRNA-760 is decreased in gastric cancer. A: MicroRNA-760 (miR-760) expression in gastric cancer tissues; B: MiR-760 expression in MKN-45, AGS, and GES-1 cells; C and D: Dysregulation of miR-760 was related to overall survival and disease-free survival in GC patients. bP < 0.01. GC: Gastric cancer; MiR-760: MicroRNA-760.
Figure 2
Figure 2
MicroRNA-760 regulates cell growth and apoptosis in gastric cancer. A: MicroRNA-760 (miR-760) expression in MKN-45 and AGS cells transfected with its mimic or inhibitor; B-D: Cell proliferation and colony formation regulated by miR-760 mimic or inhibitor; E: Flow cytometry analysis of MKN-45 and AGS cells transfected with miR-760 mimic or inhibitor. aP < 0.05, bP < 0.01. NC: Negative control; MiR-760: MicroRNA-760.
Figure 3
Figure 3
MicroRNA-760 suppresses G-protein-coupled receptor kinase interacting protein-1 expression in gastric cancer. A: The binding site between microRNA-760 (miR-760) and G-protein-coupled receptor kinase interacting protein-1 (GIT1); B: Luciferase reporter assay; C: A negative correlation between miR-760 and GIT1 in gastric cancer tissues; D and E: GIT1 expression in MKN-45 and AGS cells transfected with miR-760 mimic or inhibitor. bP < 0.01. GC: Gastric cancer; Mut: Mutant; Wt: Wild-type; 3'-UTR: 3'-untranslated region; NC: Negative control; MiR-760: MicroRNA-760; GIT1: G-protein-coupled receptor kinase interacting protein-1.
Figure 4
Figure 4
G-protein-coupled receptor kinase interacting protein-1 is upregulated in gastric cancer. A: G-protein-coupled receptor kinase interacting protein-1 (GIT1) expression in gastric cancer tissues; B: GIT1 expression in MKN-45, AGS, and GES-1 cells; C and D: High GIT1 expression was related to a shorter overall survival and disease-free survival in gastric cancer patients. bP < 0.01. GIT1: G-protein-coupled receptor kinase interacting protein-1.
Figure 5
Figure 5
MicroRNA-760 inhibits gastric cancer progression by inhibition of G-protein-coupled receptor kinase interacting protein-1. A: G-protein-coupled receptor kinase interacting protein-1 (GIT1) expression in MKN-45 and AGS cells transfected with GIT1 vector and microRNA-760 (miR-760) mimic; B-D: Cell proliferation and colony formation in MKN-45 and AGS cells transfected with GIT1 vector and miR-760 mimic; E: Flow cytometry analysis of MKN-45 and AGS cells transfected with GIT1 vector and miR-760 mimic. bP < 0.01. NC: Negative control; MiR-760: MicroRNA-760; GIT1: G-protein-coupled receptor kinase interacting protein-1.
Figure 6
Figure 6
Relevance of microRNA-760/G-protein-coupled receptor kinase interacting protein-1 axis in human gastric cancer. A: High expression of microRNA-760 was associated with a good prognosis in gastric cancer patients; B: G-protein-coupled receptor kinase interacting protein-1 (GIT1) expression in gastric cancer tissues; C: High expression of GIT1 was associated with a poor prognosis in gastric cancer patients; D: Up-regulation of GIT1 was related to cell proliferation and apoptosis in gastric cancer cells. HR: Hazard ratio; MiR-760: MicroRNA-760.

Similar articles

Cited by

References

    1. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654–2664. - PubMed
    1. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol. 2006;12:2979–2990. - PMC - PubMed
    1. Ishihara R. Infrared endoscopy in the diagnosis and treatment of early gastric cancer. Endoscopy. 2010;42:672–676. - PubMed
    1. Turaga KK, Gamblin TC, Pappas S. Surgical treatment of peritoneal carcinomatosis from gastric cancer. Int J Surg Oncol. 2012;2012:405652. - PMC - PubMed
    1. Yuan KT, Li BX, Yuan YJ, Tan M, Tan JF, Dai WG, Feng WD, Zuo JD. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways. Technol Cancer Res Treat. 2018;17:1533033818806499. - PMC - PubMed